NCT04645524 - Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions

Obstructive Sleep Apnea

Interventions

DRUG

AD182

Oral capsule administered before bed

DRUG

AD504

Oral capsule administered before bed

DRUG

Placebo

Oral capsule administered before bed

DIAGNOSTIC_TEST

Polysomnography

for all arms

Trial Locations (1)

Intrepid research, LLC, Cincinnati